The ITPR1 gene is implicated in Spinocerebellar Ataxia Type 29 (SCA29), a rare, congenital, nonprogressive neurological disorder characterized by early-onset ataxia, delayed motor development, and mild cognitive impairment. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to cause the disorder. The ITPR1 gene plays a crucial role in calcium signaling within cells, essential for various cellular processes, including coordination and motor control, which are affected in SCA29.
To diagnose SCA29 and confirm its genetic basis, a specific genetic test is available at DNA Labs UAE. This test focuses on identifying mutations in the ITPR1 gene that are responsible for the condition. Given the complexity of genetic testing and the need for precise results, the test is priced at 4400 AED. Conducting this test can provide crucial information for families affected by SCA29, enabling them to understand the genetic underpinnings of the disorder, consider genetic counseling, and make informed decisions regarding management and support for affected family members.
The ATXN3 gene test for Spinocerebellar Ataxia Type 3 (SCA3), also known as Machado-Joseph Disease, is a crucial diagnostic tool offered by DNA Labs UAE. This genetic test is aimed at detecting mutations in the ATXN3 gene, which are responsible for causing SCA3, a progressive neurodegenerative disorder. Characterized by a wide range of symptoms such as lack of coordination, difficulty with speech, and involuntary eye movements, SCA3 is inherited in an autosomal dominant manner, meaning that having just one copy of the altered gene can lead to the condition.
DNA Labs UAE provides this highly specialized test for a cost of 4400 AED. The test involves analyzing the patient's DNA to identify the specific expansion of the CAG trinucleotide repeat in the ATXN3 gene that is indicative of SCA3. Early diagnosis through this genetic testing is crucial for management and treatment planning, as well as for providing genetic counseling to affected families, helping them understand the risk of transmission to future generations.
The BEAN1 gene is associated with Spinocerebellar Ataxia Type 31 (SCA31), a neurodegenerative disorder characterized by progressive loss of coordination, speech difficulties, and eye movement abnormalities. This condition is inherited in an autosomal dominant manner, meaning that an individual only needs a single copy of the altered gene from one parent to be affected.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the BEAN1 gene that are responsible for SCA31. This test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, as it can provide a definitive diagnosis. Early detection through genetic testing can aid in managing symptoms, although there is currently no cure for SCA31.
The cost of the BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic alterations in the BEAN1 gene. Results from this test can help guide treatment decisions and allow for genetic counseling regarding the risk of passing the condition on to future generations.
The TGM6 Gene Spinocerebellar Ataxia Type 35 (SCA35) Autosomal Dominant Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TGM6 gene, which are associated with Spinocerebellar Ataxia Type 35. SCA35 is a neurodegenerative disorder characterized by a wide range of symptoms including coordination and balance difficulties, speech problems, and a gradual deterioration of motor skills. This condition is inherited in an autosomal dominant manner, meaning that an individual only needs a single copy of the mutated gene from one parent to be affected.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of specific mutations in the TGM6 gene. It is a crucial tool for families with a history of SCA35, as it can provide definitive diagnosis of the condition, inform about the risk of passing the gene to offspring, and assist in the management and treatment planning for affected individuals.
The cost of the TGM6 Gene Spinocerebellar Ataxia Type 35 Autosomal Dominant Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can offer invaluable information for affected individuals and their families, guiding healthcare decisions and providing insights into the genetic underpinnings of their condition.
The NOP56 gene is associated with Spinocerebellar Ataxia Type 36 (SCA36), a neurological disorder characterized by progressive coordination and balance difficulties due to cerebellar degeneration. This condition is inherited in an autosomal dominant manner, meaning that having just one copy of the altered gene in each cell is sufficient to cause the disorder.
DNA Labs UAE offers a specialized genetic test to identify mutations in the NOP56 gene, aiding in the diagnosis of SCA36. This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it provides definitive genetic evidence of SCA36. Early diagnosis through genetic testing can facilitate better management and intervention strategies, potentially improving quality of life.
The cost of the NOP56 gene test for Spinocerebellar Ataxia Type 36 at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis to detect the presence of specific genetic mutations associated with the disorder. Results from this test can also provide valuable information for family planning and the assessment of risk for offspring.
The PLEKHG4 gene is associated with Spinocerebellar Ataxia Type 4 (SCA4), a rare genetic disorder characterized by progressive problems with movement. This condition is part of a group of genetic disorders known as spinocerebellar ataxias, which are caused by degeneration of the cerebellum and spinal cord, leading to coordination and balance difficulties. SCA4 specifically is inherited in an autosomal dominant manner, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.
To diagnose SCA4, genetic testing is crucial. DNA Labs UAE offers a specific genetic test that identifies mutations in the PLEKHG4 gene, which can confirm a diagnosis of Spinocerebellar Ataxia Type 4. This test is particularly important for individuals with a family history of the condition or those exhibiting symptoms related to coordination and balance.
The cost of the PLEKHG4 Gene Spinocerebellar Ataxia Type 4 Autosomal Dominant Genetic Test at DNA Labs UAE is 4400 AED. This test is a significant step towards a definitive diagnosis, enabling affected individuals and their families to understand their condition better and manage it more effectively through appropriate therapeutic interventions and genetic counseling.
The SPTBN2 gene plays a crucial role in the proper functioning of the cerebellum, a part of the brain that coordinates movement and balance. Mutations in the SPTBN2 gene are associated with Spinocerebellar Ataxia Type 5 (SCA5), a rare, inherited neurological disorder characterized by progressive problems with movement and coordination. This condition is autosomal dominant, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
To diagnose SCA5, genetic testing is performed to identify mutations in the SPTBN2 gene. DNA Labs UAE offers a comprehensive genetic test specifically designed to detect these mutations. The test is crucial for individuals with a family history of SCA5 or those exhibiting symptoms related to the condition, such as difficulty with coordination and balance, to confirm the diagnosis and understand their genetic status.
The cost of the SPTBN2 gene test at DNA Labs UAE is 4400 AED. This investment provides individuals and their healthcare providers with essential information that can guide management and treatment options, as well as inform family planning decisions. Early diagnosis through genetic testing can significantly impact the quality of life for those with SCA5 and their families by enabling timely interventions and support.
The "CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the CACNA1A gene, which are implicated in Spinocerebellar Ataxia Type 6 (SCA6). SCA6 is a genetic disorder characterized by progressive degeneration of the cerebellum, leading to coordination and balance difficulties, among other symptoms. This condition follows an autosomal dominant inheritance pattern, meaning that an affected individual has a 50% chance of passing the mutation to their offspring.
The test is specifically designed to detect the presence of genetic alterations within the CACNA1A gene, which encodes a subunit of a calcium channel that plays a critical role in the functioning of nerve cells, particularly in the cerebellum. Mutations in this gene disrupt the normal flow of calcium ions, leading to the symptoms associated with SCA6.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis for individuals presenting symptoms of SCA6 or those with a family history of the disorder. It is a crucial step in confirming the diagnosis, understanding the risk of transmission to future generations, and guiding management and treatment options.
The cost of the "CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test" at DNA Labs UAE is set at 4400 AED. This investment covers the technical processes of detecting the specific genetic mutation, professional analysis, and the provision of a detailed report on the findings. It's an essential tool for individuals and families seeking clarity on their genetic status concerning SCA6, facilitating informed decisions regarding health and family planning.
The ATXN7 gene spinocerebellar ataxia type 7 (SCA7) autosomal dominant genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ATXN7 gene, which are known to cause spinocerebellar ataxia type 7. This condition is characterized by progressive deterioration of motor skills, coordination, and vision, resulting from the degeneration of specific areas in the cerebellum and retina. As an autosomal dominant disorder, only one copy of the mutated gene inherited from an affected parent is sufficient to cause the condition.
This genetic test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the ATXN7 gene that are indicative of SCA7. The process is vital for individuals with a family history of the condition or those exhibiting symptoms, as it can confirm the diagnosis, inform about the progression of the disease, and aid in family planning decisions.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the procedure and the sophisticated technology employed. Upon completion, the results provide crucial information for the management and treatment of affected individuals, offering them and their families a clearer understanding of the condition and how to navigate its challenges.
The TPP1 gene, associated with Spinocerebellar Ataxia Type 7 (SCA7), is a critical marker for this autosomal recessive genetic disorder. SCA7 is a progressive, neurodegenerative condition characterized by a loss of coordination, affecting movements and balance due to cerebellar ataxia. The condition can also lead to vision loss and other systemic symptoms. The genetic test for TPP1 gene mutations offers a definitive diagnosis, enabling early intervention and management strategies for affected individuals and their families.
At DNA Labs UAE, a specialized genetic test targeting the TPP1 gene linked to Spinocerebellar Ataxia Type 7 is available. This test is crucial for individuals with a family history of SCA7 or those exhibiting symptoms suggestive of the condition. The test is performed using a sample of the individual's blood or saliva, utilizing advanced genetic sequencing technologies to detect mutations in the TPP1 gene.
The cost of the TPP1 gene test for Spinocerebellar Ataxia Type 7 at DNA Labs UAE is 4400 AED. This price encompasses the comprehensive analysis required to identify any genetic abnormalities within the TPP1 gene. Given the complexity and the specialized nature of this genetic test, the cost reflects the extensive resources, including state-of-the-art technology and expert geneticists, necessary to provide accurate and reliable results.
By opting for this test at DNA Labs UAE, individuals gain crucial insights into their genetic makeup, empowering them with the information needed to make informed health and lifestyle decisions. Additionally, this testing can aid in the genetic counseling process, offering families a clearer understanding of their genetic heritage and the risks of transmitting the condition to future generations.
